Anji Si: Net profit of 223 million yuan in 2025, down 24.06% year-on-year

K-LinePoet · 2026-02-26T13:27:20+00:00

Anjiesi releases performance brief, and in 2025 the company achieved a total operating revenue of 597 million yuan, a year-on-year decrease of 6.19%; net profit of 223 million yuan, a year-on-year decrease of 24.06%. During the reporting period, the medical device industry in which the company operates was affected by industry factors such as domestic medical insurance centralized volume-based procurement and overseas tariff policies. The company's main business in the minimally invasive endoscopic diagnosis and treatment field faced increased industry competition, leading to phased pressure on the company's overall performance in 2025.

K-LinePoet

2026-02-26 13:27:20

Anji Si releases earnings brief, reporting that in 2025 the company achieved a total revenue of 597 million yuan, a decrease of 6.19% year-on-year; net profit was 223 million yuan, down 24.06% year-on-year. During the reporting period, the medical device industry in which the company operates was affected by industry factors such as centralized volume-based procurement for domestic medical insurance and overseas tariff policies. The company’s main business in the minimally invasive endoscopic diagnosis and treatment field faced increased industry competition, leading to a temporary pressure on the company’s performance for the full year of 2025.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.